Literature DB >> 30297519

Cognitive decline in Parkinson's disease: the impact of the motor phenotype on cognition.

Jennifer Wojtala1,2, Ines Ann Heber1, Petra Neuser3, Julia Heller1,2, Elke Kalbe4, Sarah P Rehberg4, Alexander Storch5,6, Katharina Linse5, Christine Schneider5, Susanne Gräber7, Daniela Berg7,8, Judith Dams9, Monika Balzer-Geldsetzer9,10, Rüdiger Hilker-Roggendorf4, Carola Oberschmidt11, Simon Baudrexel11, Karsten Witt12, Nele Schmidt8, Günther Deuschl7, Brit Mollenhauer13, Claudia Trenkwalder13, Inga Liepelt-Scarfone7, Annika Spottke14, Sandra Roeske14, Ullrich Wüllner14, Hans-Ulrich Wittchen15,16, Oliver Riedel17, Richard Dodel9,10, Jörg B Schulz1,2, Kathrin Reetz18,2.   

Abstract

OBJECTIVES: Parkinson's disease (PD) is the second most common neurodegenerative disorder and is further associated with progressive cognitive decline. In respect to motor phenotype, there is some evidence that akinetic-rigid PD is associated with a faster rate of cognitive decline in general and a greater risk of developing dementia.The objective of this study was to examine cognitive profiles among patients with PD by motor phenotypes and its relation to cognitive function.
METHODS: Demographic, clinical and neuropsychological cross-sectional baseline data of the DEMPARK/LANDSCAPE study, a multicentre longitudinal cohort study of 538 patients with PD were analysed, stratified by motor phenotype and cognitive syndrome. Analyses were performed for all patients and for each diagnostic group separately, controlling for age, gender, education and disease duration.
RESULTS: Compared with the tremor-dominant phenotype, akinetic-rigid patients performed worse in executive functions such as working memory (Wechsler Memory Scale-Revised backward; p=0.012), formal-lexical word fluency (p=0.043), card sorting (p=0.006), attention (Trail Making Test version A; p=0.024) and visuospatial abilities (Leistungsprüfungssystem test 9; p=0.006). Akinetic-rigid neuropsychological test scores for the executive and attentive domain correlated negatively with non-tremor motor scores. Covariate-adjusted binary logistic regression analyses showed significant odds for PD-mild cognitive impairment for not-determined as compared with tremor-dominant (OR=3.198) and akinetic-rigid PD (OR=2.059). The odds for PD-dementia were significant for akinetic-rigid as compared with tremor-dominant phenotype (OR=8.314).
CONCLUSION: The three motor phenotypes of PD differ in cognitive performance, showing that cognitive deficits seem to be less severe in tremor-dominant PD. While these data are cross-sectional, longitudinal data are needed to shed more light on these differential findings. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  Mild cognitive impairment; akinetic-rigid; cognitive profiles; cross-sectional; tremor-dominant

Year:  2018        PMID: 30297519     DOI: 10.1136/jnnp-2018-319008

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  21 in total

1.  Past appendectomy may be related to early cognitive dysfunction in Parkinson's disease.

Authors:  Alexandra R Gonçalves; Alexandre Mendes; Nuno Vila-Chã; Joana Damásio; Joana Fernandes; Sara M Cavaco
Journal:  Neurol Sci       Date:  2020-06-11       Impact factor: 3.307

2.  Parkinson's disease motor subtype changes during 20 years of follow-up.

Authors:  Robert S Eisinger; Daniel Martinez-Ramirez; Adolfo Ramirez-Zamora; Christopher W Hess; Leonardo Almeida; Michael S Okun; Aysegul Gunduz
Journal:  Parkinsonism Relat Disord       Date:  2019-05-19       Impact factor: 4.891

3.  Pre-operative cognitive burden as predictor of motor outcome following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.

Authors:  Venus Tang; Xian Lun Zhu; Claire Lau; Anne Chan; Karen Ma; Jonas Yeung; Tom Cheung; Jill Abrigo; David Yuen Chung Chan; Danny Chan; Vincent Mok; Wai Sang Poon
Journal:  Neurol Sci       Date:  2022-09-01       Impact factor: 3.830

4.  Time-course of decline in different cognitive domains in Parkinson's disease: a retrospective study.

Authors:  Christian F Altmann; Kristian Trubelja; David Emmans; Wolfgang H Jost
Journal:  J Neural Transm (Vienna)       Date:  2021-11-24       Impact factor: 3.850

5.  Executive function network's white matter alterations relate to Parkinson's disease motor phenotype.

Authors:  Qinglu Yang; Shruti Nanivadekar; Paul A Taylor; Zulin Dou; Codrin I Lungu; Silvina G Horovitz
Journal:  Neurosci Lett       Date:  2020-11-05       Impact factor: 3.046

6.  Comparing the Clinical and Neuropsychological Characteristics of Parkinson's Disease With and Without Freezing of Gait.

Authors:  Reyisha Taximaimaiti; Xiao-Ping Wang
Journal:  Front Neurosci       Date:  2021-04-27       Impact factor: 4.677

Review 7.  Aerobic Exercise and Healthy Nutrition as Neuroprotective Agents for Brain Health in Patients with Parkinson's Disease: A Critical Review of the Literature.

Authors:  Davide Maria Cammisuli; Ubaldo Bonuccelli; Simona Daniele; Claudia Martini; Jonathan Fusi; Ferdinando Franzoni
Journal:  Antioxidants (Basel)       Date:  2020-05-05

8.  Parkinson's Disease-Mild Cognitive Impairment (PD-MCI): A Useful Summary of Update Knowledge.

Authors:  Davide Maria Cammisuli; Salvatore Massimiliano Cammisuli; Jonathan Fusi; Ferdinando Franzoni; Carlo Pruneti
Journal:  Front Aging Neurosci       Date:  2019-11-08       Impact factor: 5.750

9.  The impact of distinct cognitive dual-tasks on gait in Parkinson's disease and the associations with the clinical features of Parkinson's disease.

Authors:  Halil Onder; Ozge Ozyurek
Journal:  Neurol Sci       Date:  2020-11-04       Impact factor: 3.307

10.  Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease.

Authors:  Dan Piña-Fuentes; J Marc C van Dijk; Jonathan C van Zijl; Harmen R Moes; Teus van Laar; D L Marinus Oterdoom; Simon Little; Peter Brown; Martijn Beudel
Journal:  Brain Stimul       Date:  2020-07-29       Impact factor: 8.955

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.